Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Journal of Pharmaceutical Sciences|January 1, 1990
Interaction of caffeine with L-tryptophan: study by 1H nuclear magnetic resonance spectroscopyJ Nishijo, I Yonetani, E Iwamoto, et al.Journal of Natural Products|September 1, 1989
Studies on inhibitors of skin tumor promotion, VI. Inhibitory effects of quinones on Epstein-Barr virus activationT Konoshima, M Kozuka, J Koyama, et al.Journal of Natural Products|December 1, 1995
Bruceanols G and H cytotoxic quassinoids from Brucea antidysentericaK Imamura, N Fukamiya, M Nakamura, et al.Journal of Natural Products|May 1, 1991
Picrasinoside H, a new quassinoid glucoside, and related compounds from the stem wood of Picrasma ailanthoidesT Matsuzaki, N Fukamiya, M Okano, et al.Journal of Natural Products|November 1, 1987
Antitumor agents, 90. Bruceantinoside C, a new cytotoxic quassinoid glycoside from Brucea antidysentericaN Fukamiya, M Okano, K Tagahara, et al.Journal of Natural Products|November 1, 1990
Antitumor agents, 118. The isolation and characterization of bruceanic acid A, its methyl ester, and the new bruceanic acids B, C, and D, from Brucea antidysentericaT Toyota, N Fukamiya, M Okano, et al.Journal of Pharmaceutical Sciences|November 1, 1982
Antitumor agents LV: Effects of genkwadaphnin and yuanhuacine on nucleic acid synthesis of P-388 lymphocytic leukemia cellsI H Hall, R Kasai, R Y Wu, et al.Cancer Letters|May 19, 1997
Inhibitory effects on Epstein-Barr virus activation of anthraquinones: correlation with redox potentialsJ Koyama, K Tagahara, T Osakai, et al.Cancer Letters|July 13, 2001
Inhibitory effects of anthraquinones and bianthraquinones on Epstein-Barr virus activationJ Koyama, I Morita, K Tagahara, et al.Cancer Letters|August 1, 1995
Inhibitory effects of quassinoids on Epstein-Barr virus activationM Okano, N Fukamiya, K Tagahara, et al.Pageof 3